© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
60% of women treated with the antibody-drug conjugate experienced complete or partial tumor shrinkage.
The novel immune-enhancing antibody delays disease progression, especially in people with a common genetic variant.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
